Sign in
Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome
Journal article   Open access  Peer reviewed

Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome

Roger G Whittaker, David N Herrmann, Boglarka Bansagi, Bashar Awwad Shiekh Hasan, Robert Muni Lofra, Eric L Logigian, Janet E Sowden, Jorge L Almodovar, J Troy Littleton, Stephan Zuchner, …
Neurology, Vol.85(22), pp.1964-1971
2015-12-01
PMCID: PMC4664120
PMID: 26519543

Abstract

Reflex - physiology Synaptic Transmission - physiology Humans Middle Aged Synaptotagmin II - genetics Potassium Channel Blockers - therapeutic use Reflex - drug effects Male Young Adult 4-Aminopyridine - therapeutic use Adult Female Synaptic Transmission - drug effects Child 4-Aminopyridine - pharmacology Potassium Channel Blockers - pharmacology Myasthenic Syndromes, Congenital - physiopathology Myasthenic Syndromes, Congenital - genetics Pyridostigmine Bromide - pharmacology Pyridostigmine Bromide - therapeutic use Myasthenic Syndromes, Congenital - drug therapy Adolescent 4-Aminopyridine - analogs & derivatives Aged Electrophysiological Phenomena Mutation
url
https://doi.org/10.1212/WNL.0000000000002185View
Published (Version of record) Open

Metrics

71 readers on Mendeley
1 readers on CiteULike

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.96 Cell Biology
1.96.302 Exocytosis
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details